Who founded Typewriter Therapeutics?

Typewriter Therapeutics was founded by Matthew Stanton in 2022.

Who are Typewriter Therapeutics's investors?

Typewriter Therapeutics's investors include AN Venture Partners, RA Capital, ANRI, SBI Holdings.

Typewriter Therapeutics has disclosed $112.3M raised across 2 of its 3 known rounds.

Typewriter Therapeutics is headquartered in Cambridge, US.

Cambridge, US · Founded 2022 · 5 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the Typewriter Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Developing a gene writing system to cure genetic diseases.

Typewriter Therapeutics was founded in 2022 by Matthew Stanton.

Matthew StantonFounder

Laura TadvalkarBoard director

Kenneth HorneBoard director

Mikael DolstonBoard director

Gemseki

SEC filings, press & company announcements

$112.3M disclosed across 2 of 3 rounds · 2024–2026

▶$56.3MraisedSep 2026 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does Typewriter Therapeutics do?: Developing a gene writing system to cure genetic diseases.
Who founded Typewriter Therapeutics?: Typewriter Therapeutics was founded by Matthew Stanton in 2022.
Who are Typewriter Therapeutics's investors?: Typewriter Therapeutics's investors include AN Venture Partners, RA Capital, ANRI, SBI Holdings.
How much funding has Typewriter Therapeutics raised?: Typewriter Therapeutics has disclosed $112.3M raised across 2 of its 3 known rounds.
Where is Typewriter Therapeutics headquartered?: Typewriter Therapeutics is headquartered in Cambridge, US.